Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 915051, 9 pages
http://dx.doi.org/10.1093/ecam/neq061
Original Article

San-Huang-Xie-Xin-Tang Prevents Rat Hearts from Ischemia/Reperfusion-Induced Apoptosis through eNOS and MAPK Pathways

1Department of Pharmacy, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan
2Department and Graduate Institute of Pharmacology, Kaohsiung Medical University, Kaohsiung 807, Taiwan
3Department of Paediatrics, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Taiwan
4Department of Paediatrics, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
5Graduate Institute of Engineering, National Taiwan University of Science and Technology, Taipei, Taiwan

Received 1 December 2009; Accepted 20 April 2010

Copyright © 2011 Shu-Fen Liou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. R. Hansen, “Myocardial reperfusion injury: experimental evidence and clinical relevance,” European Heart Journal, vol. 16, no. 6, pp. 734–740, 1995. View at Google Scholar · View at Scopus
  2. M. Akhlaghi and B. Bandy, “Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 46, no. 3, pp. 309–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. D. S. Burley and G. F. Baxter, “Pharmacological targets revealed by myocardial postconditioning,” Current Opinion in Pharmacology, vol. 9, no. 2, pp. 177–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. T. Shih, D. C. Wu, C. M. Liu, Y. C. Yang, I. J. Chen, and Y. C. Lo, “San-Huang-Xie-Xin-Tang inhibits Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells,” Journal of Ethnopharmacology, vol. 112, pp. 537–544, 2007. View at Google Scholar
  5. Y. C. Lo, Y. L. Lin, K. L. Yu et al., “San-Huang-Xie-Xin-Tang attenuates inflammatory responses in lipopolysaccharide-exposed rat lungs,” Journal of Ethnopharmacology, vol. 101, no. 1–3, pp. 68–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Y.-C. Lo, P.-L. Tsai, Y.-B. Huang et al., “San-Huang-Xie-Xin-Tang reduces lipopolysaccharides-induced hypotension and inflammatory mediators,” Journal of Ethnopharmacology, vol. 96, no. 1-2, pp. 99–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. H. C. Chen and M. T. Hsieh, “Hemodynamic effects of "san-huang-hsieh-hsin-tang" in patients with essential hypertension,” American Journal of Chinese Medicine, vol. 14, no. 3-4, pp. 153–156, 1986. View at Google Scholar · View at Scopus
  8. H. C. Chen and M. T. Hsieh, “Two-year experience with "San-Huang-Hsieh-Hsin-Tang" in essential hypertension,” The American Journal of Chinese Medicine, vol. 14, no. 1-2, pp. 51–58, 1986. View at Google Scholar · View at Scopus
  9. Y. T. Shih, I. J. Chen, Y. C. Wu, and Y. C. Lo, “San-Huang-Xie-Xin-Tang protects against activated microglia- and 6-OHDA-induced toxicity in neuronal SH-SY5Y cells,” Evidence-Based Complementary and Alternative Medicine. View at Publisher · View at Google Scholar
  10. Y.-B. Huang, P.-C. Wu, C.-S. Su, Y.-C. Wu, and Y.-H. Tsai, “Simultaneous quantification of twelve bioactive components in San-Huang-Xie-Xin-Tang by HPLC,” Phytochemical Analysis, vol. 17, no. 6, pp. 439–446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. S. Shia, Y. C. Hou, S. H. Juang, S. Y. Tsai, P. H. Hsieh, L. C. Ho et al., “Metabolism and pharmacokinetics of San-Huang-Xie-Xin-Tang, a polyphenol-rich Chinese medicine formula, in rats and ex-vivo antioxidant activity,” Evidence-Based Complementary and Alternative Medicine. View at Publisher · View at Google Scholar
  12. J. A. Marin-Neto, B. C. Maciel, A. L. Secches, and L. Gallo Jr., “Cardiovascular effects of berberine in patients with severe congestive heart failure,” Clinical Cardiology, vol. 11, no. 4, pp. 253–260, 1988. View at Google Scholar · View at Scopus
  13. X.-H. Zeng, X.-J. Zeng, and Y.-Y. Li, “Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy,” American Journal of Cardiology, vol. 92, no. 2, pp. 173–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Zheng, Z. Zhou, D. Tao, and T. Lan, “Protective effect of berberine on cardiac myocyte injured by ischemia-reperfusion,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 34, no. 3, pp. 452–454, 2003 (Chinese). View at Google Scholar · View at Scopus
  15. A. Y. H. Woo, C. H. K. Cheng, and M. M. Y. Waye, “Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism,” Cardiovascular Research, vol. 65, no. 1, pp. 244–253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. W.-T. Chang, Z.-H. Shao, J.-J. Yin et al., “Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes,” European Journal of Pharmacology, vol. 566, no. 1-3, pp. 58–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Y. Rhyu, K. S. Kang, M. Sekiya, and T. Yokozawa, “Antioxidant effect of Wen-Pi-Tang and its component crude drugs on oxidative stress,” American Journal of Chinese Medicine, vol. 35, no. 1, pp. 127–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-C. Liang, H.-R. Chen, C.-C. Chiu, S.-F. Liou, I.-J. Chen, and J.-L. Yeh, “Protective effect of labedipinedilol-A, a novel dihydropyridine-type calcium channel blocker, on myocardial apoptosis in ischemia-reperfusion injury,” Life Sciences, vol. 79, no. 13, pp. 1248–1256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. A. Walker, M. J. Curtis, D. J. Hearse et al., “The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion,” Cardiovascular Research, vol. 22, no. 7, pp. 447–455, 1988. View at Google Scholar · View at Scopus
  20. A. T. Demiryürek, G. Yildiz, S. Eşiyok, and S. Altuǧ, “Protective effects of poly (ADP-ribose) synthase inhibitors on digoxin-induced cardiotoxicity in guinea-pig isolated hearts,” Pharmacological Research, vol. 45, no. 3, pp. 189–194, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Fu, G. Lin, Z. Wu et al., “Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury,” Biochemical and Biophysical Research Communications, vol. 349, no. 2, pp. 504–512, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Mukhopadhyay, S. Bátkai, M. Rajesh et al., “Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity,” Journal of the American College of Cardiology, vol. 50, no. 6, pp. 528–536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Waxman and P. S. Schwartz, “Harnessing apoptosis for improved anticancer gene therapy,” Cancer Research, vol. 63, no. 24, pp. 8563–8572, 2003. View at Google Scholar · View at Scopus
  24. R. Moudgil, V. Menon, Y. Xu, S. Musat-Marcu, D. Kumar, and B. I. Jugdutt, “Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in isolated working rat hearts,” Journal of Hypertension, vol. 19, no. 6, pp. 1121–1129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Chen, C. C. Chua, Y.-S. Ho, R. C. Hamdy, and B. H. L. Chua, “Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice,” American Journal of Physiology, vol. 280, no. 5, pp. H2313–H2320, 2001. View at Google Scholar · View at Scopus
  26. G. Yang, Z. Fang, Y. Liu, H. Zhang, X. Shi, Q. Ji et al., “Protective effects of Chinese traditional medicine Buyang Huanwu decoction on myocardial injury,” Evidence-Based Complementary and Alternative Medicine. View at Publisher · View at Google Scholar
  27. H. M. Razavi, J. A. Hamilton, and Q. Feng, “Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure,” Pharmacology and Therapeutics, vol. 106, no. 2, pp. 147–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S. P. Jones, W. G. Girod, A. J. Palazzo et al., “Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase,” American Journal of Physiology, vol. 276, no. 5, pp. H1567–H1573, 1999. View at Google Scholar · View at Scopus
  29. M. S. Sumeray, D. D. Rees, and D. M. Yellon, “Infarct size and nitric oxide synthase in murine myocardium,” Journal of Molecular and Cellular Cardiology, vol. 32, no. 1, pp. 35–42, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Wolfrum, A. Dendorfer, M. Schutt et al., “Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway,” Journal of Cardiovascular Pharmacology, vol. 44, no. 3, pp. 348–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. N. Liu, Z. M. Zhou, and P. Chen, “Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening,” Clinical and Experimental Pharmacology and Physiology, vol. 35, pp. 211–216, 2008. View at Google Scholar
  32. C.-C. Hsieh and J. Papaconstantinou, “Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice,” FASEB Journal, vol. 20, no. 2, pp. 259–268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Shimada, M. Nakamura, E. Ishida, M. Kishi, and N. Konishi, “Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis,” Carcinogenesis, vol. 24, no. 6, pp. 1067–1075, 2003. View at Google Scholar · View at Scopus
  34. T.-L. Yue, C. Wang, J.-L. Gu et al., “Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart,” Circulation Research, vol. 86, no. 6, pp. 692–699, 2000. View at Google Scholar · View at Scopus
  35. M. Slevin, K. Krupinski, A. Slowik, F. Rubio, A. Szczudlik, and J. Gaffney, “Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke,” NeuroReport, vol. 11, no. 12, pp. 2759–2764, 2000. View at Google Scholar · View at Scopus
  36. S. Zhuang and R. G. Schnellmann, “A death-promoting role for extracellular signal-regulated kinase,” Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 3, pp. 991–997, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Liu, W. Mao, B. Ding, and C.-S. Liang, “ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes,” American Journal of Physiology, vol. 295, no. 5, pp. H1956–H1965, 2008. View at Publisher · View at Google Scholar · View at Scopus